U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 7-13, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 7-13, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 02/11/2021
Location: Virtual
Subject: Trust for America's Health Multisector COVID Coalition Meeting
FDA Participant/Group: DAYLE CRISTINZIO; BETH FRITSCH; PETER MARKS;
Non FDA Participant/Group: Industry, government, and other invited guests

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

Event Date: 02/11/2021
Location: Virtual
Subject: American Society of Nephrologists (ASN) Capital Markets Day for Kidney Health; Panelist: Developing an Innovation Substrate that Supports Appropriate Regulatory and Payment Policies for Kidney Health
FDA Participant/Group: JEFFREY SHUREN;
Non FDA Participant/Group: Government, industry, and other stakeholders

Official Name: Erika Anderson, Acting Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/08/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; JEFFREY FARRAR; CAITLIN BOON;
Non FDA Participant/Group: Barb Glenn, Bob Ehart, Joe Reardon, RJ Karney, Zach Gihorski (National Association of State Departments of Agriculture);

Event Date: 02/11/2021
Location: Virtual
Subject: New Era of Smarter Food Safety Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Several executives and staff from across the food industry, academia, and government

Event Date: 02/11/2021
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from the Consumer Brands Association, scientific and technical staff from industry

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/08/2021
Location: Virtual
Subject: Disease Prevention and Control Summit Group Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from the Disease Prevention and Control Summit Group

Event Date: 02/11/2021
Location: Virtual
Subject: Friends of Cancer Research - Shaping the Future of Emerging Immunotherapies and Cell Therapies Meeting; Panelist: Shaping the Future of Cell Therapies - 2021 and Beyond
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 02/11/2021
Location: Virtual
Subject: Ax-S Pharma Thursdays e-Conference Series; Panelist: The 2020 Report Card on Pre-Market Access to COVID-19 Diagnostics, Therapeutics, and Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 02/11/2021
Location: Virtual
Subject: We’re Organizing Research on Lysosomal Diseases (WORLD) Symposium Scientific Meeting; Keynote Speaker: Trailblazing a Regulatory Framework for Individualized Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top